Funding rural telehealth: what the programs actually pay against

What was broken

A healthcare startup addressing rural access gaps needed capital to fund patient outreach and a telemedicine growth plan.

What we did

CapEasy prepared the seed-fund proposal — a phased plan with budgets and projections — and aligned the application to the scheme’s eligibility and permitted-activity rules.

Where it landed

The startup secured a public seed fund approval. A seed fund approval is the incubator committee’s sanction; actual disbursement follows the scheme’s due-diligence and compliance milestones and is not guaranteed.

The R&D Tax Incentive: a telehealth platform has to prove which parts are actually R&D

The R&D Tax Incentive (R&DTI) is a self-assessed program jointly run by AusIndustry and the ATO: you register your R&D activities with AusIndustry for the income year, then claim the offset through your company tax return. For a company with aggregated turnover under $20 million, the offset is refundable and equals the corporate tax rate plus an 18.5 percentage-point premium. Above $20 million turnover, the offset is non-refundable and tiered by R&D intensity — an 8.5 percentage-point premium on notional R&D expenditure up to 2% of total expenditure, and 16.5 points above that, tapering to the company tax rate on any notional R&D deduction over $150 million in a year. Registration for a given income year is due with AusIndustry within 10 months of that year’s end, before a tax agent can lodge the claim on it.

Telehealth platforms fail the self-assessment in a specific way: triage-routing logic, a new remote-monitoring algorithm, or work to make a consult reliable over the connectivity a rural patient actually has can be core or supporting R&D if the outcome could not have been known in advance — but integrating a video SDK, building a standard booking flow, or routine app maintenance is not R&D no matter how much it serves a rural-access mission. Keeping the two streams of engineering work coded separately from the start, with the ledger able to show which project each dollar sits under, is what a self-assessment needs to survive a review.

MRFF: rural and remote is a defined geography, not a description

The Medical Research Future Fund funds a portfolio of programs rather than one open-ended pool, and several of them are built specifically for regional, rural and remote health, most directly the Regional, Rural and Remote Capacity Building grant opportunity, which supports researchers embedded in regional, rural and remote Australia doing place-based research for their communities. Some of these rounds gate eligibility on the Modified Monash Model (MMM) — the government’s remoteness classification running MM1 (major city) to MM7 (very remote) — requiring the lead organisation, the chief investigator and a defined share of research participants to sit in an MM2–7 area. A telehealth company claiming a rural-access mission should be able to show, area by area, where its patients and its research activity actually sit against the current MMM classification, not just assert "rural" in a pitch.

MRFF rounds open and close on their own calendar and are published on GrantConnect and the Department of Health’s MRFF grant opportunities calendar as they go live — the guidelines that matter are whichever round is currently open, with its own eligibility, activity scope and reporting obligations, not a remembered figure from a prior round.

Rural Health Outreach Fund: money that follows an activity, not a company

The Rural Health Outreach Fund (RHOF) funds outreach activities — medical specialists, GPs and allied health providers travelling or connecting into rural and remote communities — covering costs like travel, accommodation and backfill for the visiting provider. It is not a startup grant: funding flows through approved fund holders and outreach service providers against specific, reportable outreach activities, which is the closest AU analogue to how a telehealth platform’s clinician network actually gets paid to serve rural patients rather than how the platform itself gets capitalised. A telehealth company partnering with RHOF-funded providers needs its books able to separate platform revenue from any outreach-activity funding passing through a clinician partner, because the two sit under different reporting rules.

The throughline across R&DTI, MRFF and RHOF is the same one the engagement ran on: none of them pay against a mission statement. Each pays against a file — a registration, a geography-coded research plan, or an outreach activity report — assessed by the program or its delegate.

What application-ready rural-telehealth accounts look like

The engagement’s deliverable — a phased plan with budgets and projections built to the scheme’s own permitted-activity rules — is the same shape these AU programs ask for, adapted to what each one specifically tests. In practice that means: engineering time and cost split between core/supporting R&D activity and ordinary product work from day one, because that split is what an R&DTI self-assessment and any review turns on; patient and activity data tagged by MMM area so a rural-research or rural-access claim can be verified against the current classification rather than asserted; and outreach-activity records kept separately from platform subscription or transaction revenue where a clinician partner is drawing on RHOF or a similar fund.

CapEasy’s part in that is the bookkeeping and the file: project-level ledgers, the R&D expenditure schedule reconciled to the books, and activity records built clean enough for a registered tax agent or a program’s own assessors to work from directly. The R&DTI self-assessment, the AusIndustry registration and anything lodged with the ATO are prepared for your registered BAS or tax agent to review and lodge — eligibility and funding decisions belong to the program or its delegate, not to CapEasy.